Carrboro, NC, United States of America

Jeffrey Johnson

This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2016.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Johnson

Introduction

Jeffrey Johnson is a notable inventor based in Carrboro, NC (US). He has made significant contributions to the field of chemistry, particularly in the development of synthetic methods for complex compounds. His work has implications for various applications in pharmaceuticals and biochemistry.

Latest Patents

Johnson holds a patent titled "Synthetic route to pactamycin and pactamycin analogs." This patent describes methods and intermediates useful for making compounds of Formula (I). It includes a general method of making an alpha, beta-diamino ketone by reacting an imine with a 2-amino-substituted 1,3-dicarbonyl in a Mannich addition reaction to produce said alpha, beta-diamino ketone. He has 1 patent to his name, showcasing his innovative approach to chemical synthesis.

Career Highlights

Jeffrey Johnson is affiliated with the University of North Carolina at Chapel Hill, where he continues to engage in research and development. His academic background and professional experience have positioned him as a valuable contributor to the scientific community.

Collaborations

Throughout his career, Johnson has collaborated with talented individuals such as Justin Malinowski and Robert F. Sharpe. These partnerships have enhanced his research efforts and expanded the impact of his work.

Conclusion

In summary, Jeffrey Johnson's innovative contributions to synthetic chemistry and his patent on pactamycin analogs highlight his role as a significant inventor in his field. His work continues to influence research and development in pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…